Johnson & Johnson’s Centocor Inc. unit hid the side effects of its Remicade drug and must pay a woman with lupus symptoms $19.4 million, a Texas jury decided Wednesday.
Patricia Hamilton, 47, began taking Remicade for her Crohn’s disease in December 2001 and developed drug-induced lupus the following year, she said in her lawsuit. The drug also left her with increased risk of liver failure, said her attorney.
Hamilton sued Centocor, claiming the company failed to warn doctors of the risks of the drug. A Corpus Christi jury awarded about $3.4 million in actual damages and $16 million in punitive damages. The verdict is the first ever involving Remicade, Johnson & Johnson’s second-largest drug by sales.